NCT06127472 Psychoeducation for Older Adults With Autism
| NCT ID | NCT06127472 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tilburg University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-09-12 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-09-12 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Until recently, autism in older adults went unrecognised. Although there has been more attention to autism in older adults in recent years, there is still a lot of unfamiliarity with the phenomenon and underdiagnosis in (mental) health care. Many care providers are reluctant to diagnose autism in later life, due to a lack of knowledge about autism in older adults and because there is still very little scientific knowledge available for this target group. Although several multidisciplinary guidelines for autism in adults prescribe that after the diagnosis psycho-education is the first step in treatment, psycho-education is still only offered in a few places in the Netherlands. Psycho-education is important to help older people gain knowledge about their autism, to help them understand and accept this diagnosis, in order to subsequently make the treatment of the problems, with which they turn to the mental health care, more appropriate and effective. The aim of this study is to contribute to better recognition and diagnosis of autism among older adults. This research also aims to improve a psycho-education program for older adults and investigate its effects. The scientific research question is whether training in ASD for health care professionals results in better recognition and detection of ASD in older adults, and whether participation in the psycho-education course for older adults, who have been diagnosed with autism, or have received a probability diagnosis ASD, contributes to improvement of mental health and quality of life.
Eligibility Criteria
Inclusion Criteria: * minimum of 55 years old. * diagnosed with ASD or a probability diagnosis by a multidisciplinary team according to the Dutch multidisciplinary guideline, as confirmed by the DSM-5 interview for ASD (Spek, n.d.), or the Netherlands Interview for Diagnosis of ASD in adults (NIDA; Vuijk, 2023) Exclusion Criteria: * comorbid mental disorder that needs acute treatment and severely interferes with a group treatment (for example psychosis), * a major neurocognitive disorder (for example dementia or acquired brain injury), * substance abuse disorder, that requires detoxification, and/or * an IQ below 70.
Contact & Investigator
Arjan Videler, Dr.
PRINCIPAL INVESTIGATOR
Tilburg University, GGz Breburg
Frequently Asked Questions
Who can join the NCT06127472 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06127472 currently recruiting?
Yes, NCT06127472 is actively recruiting participants. Contact the research team at a.c.videler@tilburguniversity.edu for enrollment information.
Where is the NCT06127472 trial being conducted?
This trial is being conducted at Apeldoorn, Netherlands, Heerlen, Netherlands, Venray, Netherlands, 's-Hertogenbosch, Netherlands and 7 additional locations.
Who is sponsoring the NCT06127472 clinical trial?
NCT06127472 is sponsored by Tilburg University. The principal investigator is Arjan Videler, Dr. at Tilburg University, GGz Breburg. The trial plans to enroll 120 participants.